China BlueChemical Ltd. (HKG:3983)
Hong Kong · Delayed Price · Currency is HKD 1.950
+0.010 (0.52%)
Sep 2, 2026, 3:45 PM HKT
China BlueChemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,803 | 12,034 | 11,946 | 12,990 | 14,279 | 13,398 | |
Revenue Growth | 0.11% | 0.74% | -8.03% | -9.03% | 6.58% | 28.61% |
Cost of Revenue | 10,282 | 10,464 | 10,242 | 10,929 | 11,742 | 10,462 |
Gross Profit | 1,521 | 1,571 | 1,705 | 2,061 | 2,537 | 2,936 |
Selling, General & Admin | 790.34 | 780.73 | 720.41 | 717.58 | 665.34 | 660.81 |
Other Operating Expenses | 93.81 | 90.84 | 17.9 | 27.72 | 47.4 | 50.42 |
Operating Expenses | 884.17 | 871.58 | 739.04 | 751.48 | 720.52 | 711.23 |
Operating Income | 636.9 | 698.97 | 965.58 | 1,310 | 1,816 | 2,225 |
Interest Expense | -42.26 | -45.85 | -52.76 | -34.19 | -29.39 | -50.56 |
Interest & Investment Income | 327.86 | 331.18 | 351.08 | 357.94 | 314.82 | 372.71 |
Earnings From Equity Investments | 146.17 | 123.93 | 49.01 | 4.03 | 5.43 | 3.32 |
Currency Exchange Gain (Loss) | -11.18 | -4.47 | -3.59 | -9.62 | 9.36 | 0.36 |
Other Non Operating Income (Expenses) | 195.75 | 258.14 | 88.5 | 89.72 | 76.66 | 115.14 |
EBT Excluding Unusual Items | 1,253 | 1,362 | 1,398 | 1,717 | 2,193 | 2,666 |
Gain (Loss) on Sale of Investments | 9.87 | 32.67 | 69.4 | 88.28 | 93.04 | 539.01 |
Gain (Loss) on Sale of Assets | 6.02 | 11.13 | - | 858.23 | 0.42 | 47.46 |
Asset Writedown | -221.67 | -39.86 | - | - | -15.69 | -302.57 |
Other Unusual Items | -0.02 | - | - | - | - | -308.44 |
Pretax Income | 1,047 | 1,366 | 1,467 | 2,664 | 2,271 | 2,642 |
Income Tax Expense | 249.43 | 249.8 | 316.09 | 289.89 | 472.04 | 1,000 |
Earnings From Continuing Operations | 798.01 | 1,116 | 1,151 | 2,374 | 1,799 | 1,641 |
Minority Interest in Earnings | 43.32 | -141.6 | -79.86 | 7.58 | -156.15 | -143.84 |
Net Income | 841.33 | 974.44 | 1,071 | 2,382 | 1,643 | 1,498 |
Net Income to Common | 841.33 | 974.44 | 1,071 | 2,382 | 1,643 | 1,498 |
Net Income Growth | -17.92% | -9.04% | -55.02% | 45.00% | 9.68% | 100.89% |
Shares Outstanding (Basic) | 4,610 | 4,610 | 4,610 | 4,610 | 4,610 | 4,610 |
Shares Outstanding (Diluted) | 4,610 | 4,610 | 4,610 | 4,610 | 4,610 | 4,610 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 0.18 | 0.21 | 0.23 | 0.52 | 0.36 | 0.32 |
EPS (Diluted) | 0.18 | 0.21 | 0.23 | 0.52 | 0.36 | 0.32 |
EPS Growth | -17.92% | -9.04% | -55.02% | 45.00% | 9.68% | 100.89% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | 965.97 | 921.2 | 925.45 | 806.7 | 1,879 |
Free Cash Flow Per Share | - | 0.21 | 0.20 | 0.20 | 0.17 | 0.41 |
Dividend Per Share | 0.112 | 0.112 | 0.121 | 0.207 | 0.178 | 0.155 |
Dividend Growth | -7.29% | -7.29% | -41.64% | 16.29% | 14.84% | 93.75% |
Gross Margin | 12.89% | 13.05% | 14.27% | 15.87% | 17.77% | 21.92% |
Operating Margin | 5.40% | 5.81% | 8.08% | 10.08% | 12.72% | 16.61% |
Profit Margin | 7.13% | 8.10% | 8.97% | 18.34% | 11.50% | 11.18% |
Free Cash Flow Margin | - | 8.03% | 7.71% | 7.12% | 5.65% | 14.03% |
EBITDA | 1,210 | 1,287 | 1,579 | 1,892 | 2,343 | 2,758 |
EBITDA Margin | 10.25% | 10.70% | 13.22% | 14.56% | 16.41% | 20.58% |
D&A For EBITDA | 572.89 | 588.4 | 613.81 | 582.12 | 526.59 | 532.54 |
EBIT | 636.9 | 698.97 | 965.58 | 1,310 | 1,816 | 2,225 |
EBIT Margin | 5.40% | 5.81% | 8.08% | 10.08% | 12.72% | 16.61% |
Effective Tax Rate | 23.81% | 18.29% | 21.54% | 10.88% | 20.79% | 37.86% |